Ellen F. Mochizuki Net Worth

What's Ellen Mochizuki's mailing address?

Ellen's mailing address filed with the SEC is 1880 CENTURY PARK EAST, SUITE 1000, , LOS ANGELES,, CA, 90067.

Insiders trading at Ritter Pharmaceuticals

Over the last 9 years, insiders at Ritter Pharmaceuticals have traded over 124,250$ worth of Ritter Pharmaceuticals stock and bought 1,819,751 units worth 8,518,572$ . The most active insiders traders include Noah Doyle、Venture Partners, L.P. Javelin、Matthew W Foehr. On average, Ritter Pharmaceuticals executives and independent directors trade stock every 86 days with the average trade being worth of 1,400,057$. The most recent stock trade was executed by Noah Doyle on 12 March 2020, trading 500,000 units of RTTR stock currently worth 110,000$.

What does Ritter Pharmaceuticals do?

Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat digestive disorders and gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was founded by Andrew J. Ritter and Ira E. Ritter on March 29, 2004 and is headquartered in Los Angeles, CA.

Ritter Pharmaceuticals executives and stock owners

Ritter Pharmaceuticals executives and other stock owners filed with the SEC include:

• Ira Ritter,
  Director
• Amy Broidrick,
  Independent Director
• Kurt Kruger,
  Independent Director
• Matthew Korenberg,
  Independent Director
• Richard David,
  Independent Director
• Shishir Sinha,
  Vice President - Operations
• Wajdi Abdul-Ahad,
  Chief Scientific Officer, Vice President - Research & Development
• Christopher Lotz,
  Chief Financial Officer, Vice President - Finance
• Michael Poirier,
  Chairman of the Board, President, Chief Executive Officer
• Paul V Maier,
  Director
• Michael D Step,
  CEO
• William M. Merino,
  Director
• Ellen F. Mochizuki,
  VP, Finance
• Partners Llc Stonehenge,
  10% owner
• Matthew W Foehr,
  Director
• Gerald T Proehl,
  Director
• Venture Partners, L.P. Javelin,
  10% owner
• Andrew J Ritter,
  CEO and President
• Noah Doyle,
  Director
• Jeffrey S Benjamin,
  VP of Finance
• John W Beck,
  Chief Financial Officer
• Venture Partners I Spv I, L...,
  10% owner